alexa Glucose-Regulated Protein 78: A Novel Therapeutic Target for Amelogenin- Induced Periodontal Tissue Regeneration | OMICS International
ISSN: 2168-9431
Single Cell Biology
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Glucose-Regulated Protein 78: A Novel Therapeutic Target for Amelogenin- Induced Periodontal Tissue Regeneration

Takao Fukuda1,*,#, Terukazu Sanui1,*,#, Kyosuke Toyoda1, Urara Tanaka1, Kensuke Yamamichi1, Takaharu Taketomi2, and Fusanori Nishimura1

Department of Periodontology, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, Fukuoka, Japan

2Dental and Oral Medical Center, Kurume University School of Medicine, Kurume, Fukuoka, Japan

#These authors contributed equally to this article

Corresponding Author:
Takao Fukuda
D.D.S., PhD, Assistant Professor
Department of Periodontology, Division of Oral
Rehabilitation, Faculty of Dental Science, Kyushu University
3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Tel: +81-92-642-6358
Fax: +81-92-642-6360
E-mail: [email protected]
Terukazu Sanui
D.D.S., PhD, Lecturer, Department of Periodontology
Division of Oral Rehabilitation, Faculty of Dental Science
Kyushu University, 3-1-1 Maidashi, Higashi-ku
Fukuoka 812-8582, Japan
Tel: +81-92-642-6358
Fax: +81-92-642- 6360
E-mail: [email protected]

Received date: April 29, 2016; Accepted date: May 09, 2016; Published date: May 11, 2016

Citation: Fukuda T, Sanui T, Toyoda K, Tanaka U, Yamamichi K, et al. (2016) Glucose- Regulated Protein 78: A Novel Therapeutic Target for Amelogenin-Induced Periodontal Tissue Regeneration. Single Cell Biol 5:137. doi:10.4172/2168-9431.1000137

Copyright: © 2016 Fukuda T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Single Cell Biology

Abstract

Amelogenin, the major component of a commercial enamel matrix derivative (Straumann® Emdogain), is commonly employed in periodontology. It is mainly used in periodontal surgery to stimulate the regeneration of periodontal tissues, including the cementum, periodontal ligament, and alveolar bone. However, the precise molecular mechanisms underlying amelogenin-induced regeneration have not yet been elucidated. Thus, to gain further insight into how amelogenin induces periodontal tissue regeneration, we performed a protein interaction screen using recombinant full-length amelogenin (rM180) as bait. Coupling affinity chromatography with proteomic analysis identified glucose-regulated protein 78 (Grp78) as a new amelogenin-binding protein. We further demonstrated that the interaction between amelogenin and Grp78 not only contributes to cell proliferation in osteoblastic cells but also enhances cell migration in periodontal ligament stem/progenitor cells. Although the potentiation effects of Grp78 should be further examined in vivo, our findings indicate the significant therapeutic potential for amelogenin-induced periodontal tissue regeneration.

Keywords

Glucose-regulated protein 78 (Grp78); Amelogenin; Extracellular matrix (ECM)

Commentary

The periodontium is mainly composed of two hard tissues and two soft tissues; the former include the alveolar bone and cementum covering the tooth root, and the latter include the periodontal ligament (PDL) tissue and gingival tissue. Periodontal disease is characterized by irretrievable damage of the tooth-supporting periodontium and is the major cause of tooth loss in adults. However, the conventional subgingival root debridement or periodontal flap surgery can only help to prevent the progression of periodontal disease and do not provide a cure. Various types of periodontal regeneration strategies have been developed to date, and application of the extracellular matrix (ECM) has been proposed as one of the most successful therapeutic strategies [1]. The ECM is well known to serve as a biological scaffold for tissue regeneration by modulating cells through the transduction of a variety of signaling pathways [2]. Furthermore, the ECM contributes to angiogenesis, recruitment of stem/progenitor cells, and remodeling of damaged tissues [3].

Enamel matrix derivative (EMD) (Straumann® Emdogain) was developed according to a concept of mimicking the tooth developmental environment [4]. EMD has been widely applied for periodontal tissue regeneration, and long-term successful clinical results have been obtained [5]. Many in vitro studies have supported the notion that EMD not only contributes to osteoconductive activity [6] but also enhances the multi-lineage differentiation of human PDL cells [7]. Amelogenins, the major (>95%) component of EMD, belong to the ECM protein family [8]. During tooth development, ameloblasts secrete amelogenins onto the dentin root surface [9]. Consequently, amelogenin induces the formation of the PDL, thereby promoting alveolar bone formation [10]. As an ECM protein, amelogenin (Xelma®, Molnlycke Health Care, and Gothenburg, Sweden) has also been used as an effective and standard treatment for hard-to-heal wounds [11]. Moreover, recent studies have demonstrated that recombinant amelogenin alone could induce in vivo periodontal tissue regeneration [12]. Although amelogenins have been suggested to serve as bioactive candidates for periodontal regeneration [4], their downstream signaling molecules have not been clearly elucidated.

To gain further insight into the molecular basis of amelogenininduced periodontal tissue regeneration, we performed an affinity chromatography-based proteomic analysis to identify amelogeninspecific binding proteins in osteoblastic cells [13]. After confirming the endocytosis of recombinant amelogenin as a precondition for physiological interaction, we found that glucose-regulated protein 78 (Grp78) was the only protein present in both the cytosolic and membrane fractions of the osteoblastic cell lysate. Grp78 is a member of the heat shock protein 70 family and is well known as an endoplasmic reticulum (ER) chaperone, which regulates the ER stress signaling pathway [14]. Recent studies have demonstrated that ER stress signaling mediates bone formation [15], and we found that the biological interaction between amelogenin and Grp78 contributed to osteoblastic cell proliferation.

PDLSCs play a central role in regenerating the periodontium, possess a self-renewal property, and differentiate into fibroblasts, osteoblasts, or cementoblasts in response to stimuli in their microenvironment [16]. As successful periodontal regeneration requires the participation of mesenchymal stem cell (MSC)-derived PDL stem cells (PDLSCs) [17], we also evaluated the interaction using the PDLSC [18]. Although Grp78 is located mainly in the ER, in stem/progenitor cells and undifferentiated tumor cells, it translocates to the cell surface, where it acts as a receptor for cell-surface signalling [19-21]. Consistent with these reports of the cell surface localization of Grp78, our confocal analysis confirmed the cell surface co-localization of amelogenin with Grp78, and showed that Grp78 specifically mediates the endocytosis of amelogenin. Considering the cell surface localization of Grp78 in PDLSCs, Grp78 appears to be an amelogenin-specific receptor in PDLSCs. We also found that the biological interaction between Grp78 and amelogenin contributes to cell migration without affecting cell proliferation. Cell migration involves cytoskeletal reorganization and induce the formation of membrane protrusions in the forms of lamellipodia and filopodia [22]. Small GTPases of the Rho family, Rac1, Cdc42, and Rho, are key molecules for cytoskeletal dynamics and control the formation of lamellipodia, filopodia, and stress fibers, respectively [23]. We further demonstrated that Rac1 activation and lamellipodia formation are critical in amelogenin-induced cell migration in PDLSCs.

In conclusion, the biological interaction of amelogenin with Grp78 shows significant therapeutic potential for amelogenin-induced periodontal tissue regeneration. The results of our in vitro studies suggest the possibility that this interaction in osteoblasts can lead to bone regeneration, and the resulting enhanced migration of PDLSCs is an essential component for the initiation of periodontal tissue regeneration. Considering that the commercial product Straumann® Emdogain is derived from the porcine EMD, development of a new procedure through the combination of recombinant amelogenin and a Grp78 inducer could be a safe and reliable therapeutic strategy based on the clinical achievement of Straumann® Emdogain and the molecular basis of amelogenin. Although these effects should be further examined in vivo, our findings indicate the significant therapeutic potential for amelogenin-induced periodontal tissue regeneration (Figure 1).

single-cell-biology-schematic-image

Figure 1: A schematic image for the clinical application. Therapeutic model for amelogenin-induced periodontal tissue regeneration by the Fcomigbinuatrioen of1 re:c oAmb insacnth ameemlogaentiinc a nidm a Garpg7e8 i nfdoucre r tPhDLe c ecllsl:i nPeircioadoln taal pLigpalmicenat Ctieollsn, O. BT cehllse: rOastpeoeblausttiicc C emlls.odel for amelogenin-induced periodontal tissue regeneration by the combination of
recombinant amelogenin and a Grp78 inducer PDL cells: Periodontal Ligament Cells, OB cells: Osteoblastic Cells.

Contract Grant Sponsor

Grants-in-Aid for Scientific Research C (26463137) and Research Activity Start-up (15H06492) from the Japan Society for the Promotion of Science

Acknowledgments

This work was supported by Grants-in-Aid for Scientific Research C (26463137) and Research Activity Start-up (15H06492) from the Japan Society for the Promotion of Science.

Author Disclosure Statement

The authors have declared that no conflicts of interest exist.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 7th International Conference and Exhibition on Cell and Gene Therapy
    March 15-17, 2018 London,UK
  • Global Experts Meeting On Cell and Gene Therapy
    April 25-26, 2018 Dubai, UAE
  • 2nd Annual summit on Cell Metabolism 2018
    September 19 - 20, 2018 Philadelphia, USA

Article Usage

  • Total views: 8265
  • [From(publication date):
    June-2016 - Dec 18, 2017]
  • Breakdown by view type
  • HTML page views : 8192
  • PDF downloads : 73

Review summary

  1. Arthur Black
    Posted on Aug 18 2016 at 12:17 pm
    The article depicts the presence of interaction between Grp78 and Amelogenin stimulated regeneration of periodontal tissues. The significance of the study is to elucidate downstream signaling of Amelogenin.
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version